1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Neonatal Seizures Global Clinical Trials Review, H2, 2014

Neonatal Seizures Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neonatal Seizures. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neonatal Seizures. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Neonatal Seizures Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Neonatal Seizures 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Neonatal Seizures to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Neonatal Seizures to Central Nervous System Clinical Trials 15
Clinical Trials in E7 Countries by Trial Status 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Neonatal Seizures 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Drugs 24
Clinical Trial Overview of Top Institutes / Government 25
University of California, San Diego 25
Clinical Trial Overview of University of California, San Diego 25
Cincinnati Children's Hospital Medical Center 26
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 26
LLRM Medical College 27
Clinical Trial Overview of LLRM Medical College 27
Academic Medical Center 28
Clinical Trial Overview of Academic Medical Center 28
Aga Khan University 29
Clinical Trial Overview of Aga Khan University 29
Erasmus MC 30
Clinical Trial Overview of Erasmus MC 30
University of Rochester 31
Clinical Trial Overview of University of Rochester 31
Washington University School of Medicine 32
Clinical Trial Overview of Washington University School of Medicine 32
Boston Children's Hospital 33
Clinical Trial Overview of Boston Children's Hospital 33
University Hospital, Limoges 34
Clinical Trial Overview of University Hospital, Limoges 34
Five Key Clinical Profiles 35
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Disclaimer 52
Source 52

List of Tables
Neonatal Seizures Therapeutics, Global, Clinical Trials by Region, 2014* 6
Neonatal Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Neonatal Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Neonatal Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 9
Neonatal Seizures Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Neonatal Seizures Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Neonatal Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Neonatal Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Neonatal Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Neonatal Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Neonatal Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 16
Neonatal Seizures Therapeutics, Global, Clinical Trials by Phase, 2014* 17
Neonatal Seizures Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 18
Neonatal Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Neonatal Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Neonatal Seizures Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Neonatal Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Neonatal Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Neonatal Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2014* 25
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014* 26
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by LLRM Medical College, 2014* 27
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 28
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2014* 29
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 30
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 31
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 32
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Children's Hospital, 2014* 33
Neonatal Seizures Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Limoges, 2014* 34

List of Figures
Neonatal Seizures Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Neonatal Seizures Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Neonatal Seizures Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Neonatal Seizures Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 9
Neonatal Seizures Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Neonatal Seizures Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Neonatal Seizures to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Neonatal Seizures Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Neonatal Seizures Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Neonatal Seizures to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Neonatal Seizures Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 16
Neonatal Seizures Therapeutics, Global, Clinical Trials by Phase (%), 2014* 17
Neonatal Seizures Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 18
Neonatal Seizures Therapeutics, Global, Clinical Trials by Trial Status, 2014* 19
Neonatal Seizures Therapeutics Clinical Trials, Global, by End Point Status, 2014* 20
Neonatal Seizures Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Neonatal Seizures Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Neonatal Seizures Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 24
GlobalData Methodology 51

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.